Literature DB >> 7926723

Novel insights into erythroid development revealed through in vitro differentiation of GATA-1 embryonic stem cells.

M J Weiss1, G Keller, S H Orkin.   

Abstract

Mouse embryonic stem (ES) cells lacking the transcription factor GATA-1 do not produce mature red blood cells either in vivo or in vitro. To define the consequences of GATA-1 loss more precisely, we used an in vitro ES cell differentiation assay that permits enumeration of primitive (EryP) and definitive (EryD) erythroid precursors and recovery of pure erythroid colonies. In contrast to normal ES cells, GATA-1- ES cells fail to generate EryP precursors. EryD precursors, however, are normal in number but undergo developmental arrest and death at the proerythroblast stage. Contrary to initial expectations, arrested GATA-1(-)-definitive proerythroblasts express GATA target genes at normal levels. Transcripts of the related factor GATA-2 are remarkably elevated in GATA-1- proerythroblasts. These findings imply substantial interchangeability of GATA factors in vivo and suggest that GATA-1 normally serves to repress GATA-2 during erythropoiesis. The approach used here is a paradigm for the phenotypic analysis of targeted mutations affecting hematopoietic development.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7926723     DOI: 10.1101/gad.8.10.1184

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  173 in total

1.  Inositol polyphosphate 4-phosphatase type I regulates cell growth downstream of transcription factor GATA-1.

Authors:  P Vyas; F A Norris; R Joseph; P W Majerus; S H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

Review 2.  The end is just the beginning: megakaryocyte apoptosis and platelet release.

Authors:  J Li; D J Kuter
Journal:  Int J Hematol       Date:  2001-12       Impact factor: 2.490

3.  The zinc-finger proto-oncogene Gfi-1b is essential for development of the erythroid and megakaryocytic lineages.

Authors:  Shireen Saleque; Scott Cameron; Stuart H Orkin
Journal:  Genes Dev       Date:  2002-02-01       Impact factor: 11.361

4.  Inhibition of CBP-mediated protein acetylation by the Ets family oncoprotein PU.1.

Authors:  Wei Hong; Alexander Y Kim; Sokun Ky; Carrie Rakowski; Sang-Beom Seo; Debabrata Chakravarti; Michael Atchison; Gerd A Blobel
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

5.  An upstream, DNase I hypersensitive region of the hematopoietic-expressed transcription factor GATA-1 gene confers developmental specificity in transgenic mice.

Authors:  M A McDevitt; Y Fujiwara; R A Shivdasani; S H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

6.  ABC-me: a novel mitochondrial transporter induced by GATA-1 during erythroid differentiation.

Authors:  O S Shirihai; T Gregory; C Yu; S H Orkin; M J Weiss
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

7.  Leukemogenesis caused by incapacitated GATA-1 function.

Authors:  Ritsuko Shimizu; Takashi Kuroha; Osamu Ohneda; Xiaoqing Pan; Kinuko Ohneda; Satoru Takahashi; Sjaak Philipsen; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

Review 8.  Challenges and promises for the development of donor-independent platelet transfusions.

Authors:  Michele P Lambert; Spencer K Sullivan; Rudy Fuentes; Deborah L French; Mortimer Poncz
Journal:  Blood       Date:  2013-01-15       Impact factor: 22.113

Review 9.  EKLF/KLF1, a tissue-restricted integrator of transcriptional control, chromatin remodeling, and lineage determination.

Authors:  Yvette Y Yien; James J Bieker
Journal:  Mol Cell Biol       Date:  2012-10-22       Impact factor: 4.272

10.  Tissue-specific mitotic bookmarking by hematopoietic transcription factor GATA1.

Authors:  Stephan Kadauke; Maheshi I Udugama; Jan M Pawlicki; Jordan C Achtman; Deepti P Jain; Yong Cheng; Ross C Hardison; Gerd A Blobel
Journal:  Cell       Date:  2012-08-17       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.